Piyasa kapalı· · AUD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Clover Corp Ltd (ASX:CLV) capped FY26 with record revenue of $97.4 million and a 50% jump in NPAT, as ARA momentum and a debt-free balance sheet set the stage for a stronger first half of FY27.
As Australian shares prepare for a modest rise, the local market is closely watching economic indicators such as job advertisements and building approvals, alongside international developments like U.S.-Iran peace talks. For investors considering smaller or newer companies, penny stocks—despite their somewhat outdated name—remain an intriguing area of investment. These stocks can offer surprising value and growth potential when backed by strong financials, making them worth considering for...
Clover Corporation Limited (ASX:CLV) CEO & managing director Peter Davey talked with Proactive at the ASX Small and Mid-Cap Conference about the company’s technology-driven approach to delivering omega-3 and omega-6 nutritional solutions, and how this is supporting strong global growth. Davey explained that Clover specialises in microencapsulation technology, which allows oils such as fish, algal and fungal oils to be converted into powder form. This process removes taste and smell while preserving nutritional benefits, enabling integration into a wide range of food and beverage products. As h
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.